Acadian Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$177K Sell
12,807
-55,854
-81% -$890K ﹤0.01% 1620
2025
Q4
$1.11M Buy
68,661
+43,320
+171% +$707K ﹤0.01% 1093
2025
Q3
$378K Sell
25,341
-45,716
-64% -$557K ﹤0.01% 1279
2025
Q2
$826K Sell
71,057
-112,056
-61% -$1.02M ﹤0.01% 1017
2025
Q1
$1.36M Buy
183,113
+56,058
+44% +$431K ﹤0.01% 853
2024
Q4
$760K Sell
127,055
-50,634
-28% -$279K ﹤0.01% 981
2024
Q3
$908K Buy
+177,689
New +$774K ﹤0.01% 936
2024
Q2
Sell
-162,137
Closed -$519K 1731
2024
Q1
$519K Buy
+162,137
New +$627K ﹤0.01% 995
2020
Q2
Sell
-3,145
Closed -$87K 2211
2020
Q1
$87K Sell
3,145
-305
-9% -$8.51K ﹤0.01% 1377
2019
Q4
$103K Buy
+3,450
New +$99.1K ﹤0.01% 1446

Other funds holding ADPT